Northstar Group’s Medtronic MDT Stock Holding History

Northstar Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$211K	Sell	2,440 -100	-4%	-$9.58K	0.03%	159
2025 Q4	$244K	Hold	2,540	–	–	0.03%	152
2025 Q3	$242K	Hold	2,540	–	–	0.04%	141
2025 Q2	$221K	Hold	2,540	–	–	0.03%	146
2025 Q1	$228K	Hold	2,540	–	–	0.04%	141
2024 Q4	$203K	Hold	2,540	–	–	0.03%	150
2024 Q3	$229K	Sell	2,540 -131	-5%	-$11K	0.04%	139
2024 Q2	$210K	Buy	2,671 +95	+4%	+$7.79K	0.04%	138
2024 Q1	$225K	Hold	2,576	–	–	0.04%	140
2023 Q4	$212K	Hold	2,576	–	–	0.05%	137
2023 Q3	$202K	Sell	2,576 -33	-1%	-$2.76K	0.05%	137
2023 Q2	$230K	Buy	2,609 +53	+2%	+$4.56K	0.05%	135
2023 Q1	$206K	Buy	+2,556	New	+$208K	0.05%	138
2022 Q4	–	Sell	-2,650	Closed	-$213K	–	136
2022 Q3	$213K	Buy	2,650 +90	+4%	+$8.09K	0.06%	127
2022 Q2	$229K	Hold	2,560	–	–	0.07%	127
2022 Q1	$284K	Sell	2,560 -72	-3%	-$7.61K	0.07%	129
2021 Q4	$272K	Buy	2,632 +10	+0.4%	+$1.16K	0.06%	138
2021 Q3	$328K	Hold	2,622	–	–	0.09%	123
2021 Q2	$325K	Hold	2,622	–	–	0.09%	121
2021 Q1	$310K	Sell	2,622 -132	-5%	-$15.5K	0.09%	121
2020 Q4	$322K	Hold	2,754	–	–	0.1%	114
2020 Q3	$286K	Sell	2,754 -491	-15%	-$49.3K	0.1%	116
2020 Q2	$298K	Sell	3,245 -241	-7%	-$23.1K	0.12%	106
2020 Q1	$314K	Sell	3,486 -1,221	-26%	-$130K	0.14%	100
2019 Q4	$534K	Buy	4,707 +4	+0.1%	+$439	0.2%	80
2019 Q3	$511K	Sell	4,703 -88	-2%	-$9.18K	0.21%	80
2019 Q2	$466K	Sell	4,791 -95	-2%	-$8.67K	0.2%	85
2019 Q1	$445K	Sell	4,886 -246	-5%	-$22K	0.2%	89
2018 Q4	$467K	Sell	5,132 -96	-2%	-$8.97K	0.24%	82
2018 Q3	$515K	Buy	5,228 +83	+2%	+$7.67K	0.24%	82
2018 Q2	$440K	Sell	5,145 -284	-5%	-$23.7K	0.22%	87
2018 Q1	$435K	Sell	5,429 -700	-11%	-$57.7K	0.23%	83
2017 Q4	$495K	Hold	6,129	–	–	0.26%	79
2017 Q3	$477K	Sell	6,129 -100	-2%	-$8.3K	0.28%	79
2017 Q2	$553K	Hold	6,229	–	–	0.34%	69
2017 Q1	$505K	Sell	6,229 -550	-8%	-$43K	0.33%	70
2016 Q4	$472K	Buy	6,779 +978	+17%	+$76.8K	0.33%	69
2016 Q3	$501K	Buy	5,801 +2,800	+93%	+$244K	0.36%	69
2016 Q2	$260K	Hold	3,001	–	–	0.19%	88
2016 Q1	$225K	Hold	3,001	–	–	0.17%	90
2015 Q4	$231K	Hold	3,001	–	–	0.18%	95
2015 Q3	$213K	Hold	3,001	–	–	0.17%	98
2015 Q2	$222K	Hold	3,001	–	–	0.17%	102
2015 Q1	$234K	Buy	+3,001	New	+$227K	0.18%	101

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northstar Group's MDT Position: Q1 2026 in Review

Northstar Group reduced its Medtronic (MDT) stake by 3.9% in Q1 2026, selling an estimated $9.58K and leaving 2,440 shares worth $211K. The position accounts for 0.03% of the portfolio, ranked #159.

Northstar Group first reported a position in MDT in Q1 2015 and has held it in 44 quarters since. The position peaked at $553K in Q2 2017. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Northstar Group held 2,440 shares of Medtronic worth $211K as of Q1 2026.
Northstar Group sold 100 Medtronic shares in Q1 2026, an estimated $9.58K.
Medtronic made up 0.03% of Northstar Group's portfolio in Q1 2026, its #159 holding.
Northstar Group first reported a position in Medtronic in Q1 2015 and has held it in 44 quarters since.
Northstar Group's Medtronic position peaked at $553K in Q2 2017.
2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Northstar Group's 13F filing for Q1 2026, filed 28 Apr 2026.